Through Smads signaling, TGF-β1 is a well known inducer of EMT leading to tumor metastasis progression, and our data suggest that TGF-β1 promotes EMT by increasing the expression of HMGA1, offering a novel pathway for TGF-β1-induced EMT in breast cancer. Here, HMGA1 is linked to breast cancer.